UNIVAXX is a privately held company focused on developing vaccines against viral pandemics. The company has patent pending and proprietary intellectual property regarding its vaccine technology. There are no scientific, technical or regulatory barriers to developing these novel vaccines.

UNIVAXX is seeking a strategic partner to co-develop these vaccines.

Please use the contact form below if you have any questions or would like more information.